Atlas Trials

Rifaximin in Fatty Liver Disease

Clinical trial NCT01355575 · TERMINATED

Trial details

NCT number
NCT01355575
Sponsor
Imperial College London
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Nonalcoholic Fatty Liver DiseaseNAFLDNonalcoholic Steatohepatitis
Start date
2011-05-01
Primary completion
2012-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.